Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Actinium Pharmaceuticals Inc

CUSIP: 00507W956 | 5 institutional holders

Quarters

Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile